Fig. 2From: Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysisIncidences of nausea, vomiting and decreased appetite for 5 days after the initiation of carboplatin treatment on day 1Back to article page